STOCK TITAN

Insider sale notice — EPR (NYSE: EPR) lists 2 deferred awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

EPR reported a Form 144 notice indicating proposed sales of Common Stock tied to deferred stock awards to Gwendolyn M. Johnson. The excerpt lists 515 shares dated 01/02/2024 and 1,485 shares dated 01/02/2025 as awarded under deferred compensation/stock award entries.

Positive

  • None.

Negative

  • None.

Insights

Routine insider resale notice tied to deferred awards.

The filing lists deferred compensation stock awards to Gwendolyn M. Johnson of 515 shares (01/02/2024) and 1,485 shares (01/02/2025). These appear as award entries; the Form 144 framework notifies the SEC of intended resale.

Cash‑flow treatment and timing of any actual sale are not disclosed in the excerpt; subsequent filings would show completion details and proceeds.

Awarded shares (01/02/2024) 515 shares Stock Award/Deferred Compensation to Gwendolyn M. Johnson
Awarded shares (01/02/2025) 1,485 shares Stock Award/Deferred Compensation to Gwendolyn M. Johnson
Form type Form 144 Notice of proposed sale of securities
Form 144 regulatory
"Securities To Be Sold / Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Deferred Compensation financial
"Stock Award/Deferred Compensation entries for Gwendolyn M. Johnson"
Deferred compensation is pay that employees or executives have earned now but will receive at a later date, such as delayed bonuses, retirement benefits, or stock grants. It matters to investors because it creates future obligations and shapes incentives—like a promise to pay later that can affect a company’s reported profits, cash needs and potential stock dilution—so it helps signal how a business manages costs and retains key people.
Stock Award financial
"01/02/2024 | Stock Award/Deferred Compensation"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the EPR Form 144 filing report?

The filing reports proposed sales of Common Stock tied to deferred stock awards to Gwendolyn M. Johnson. It lists 515 shares dated 01/02/2024 and 1,485 shares dated 01/02/2025.

Are the shares in the EPR excerpt already sold?

No; the excerpt lists award entries and a Form 144 notice, which signals intent to sell but does not confirm completed sales. Completion and proceeds are not shown in the provided text.

Who is the reporting person in the Form 144 excerpt?

The excerpt identifies the recipient of the deferred awards as Gwendolyn M. Johnson. The filing shows award dates and share counts tied to her deferred compensation entries.

What amounts of stock are involved in the EPR Form 144 excerpt?

The excerpt shows two award entries: 515 shares with date 01/02/2024 and 1,485 shares with date 01/02/2025, both described as deferred compensation/stock awards.

Does the Form 144 excerpt state how sale proceeds will be used?

The provided excerpt does not disclose any use of proceeds or cash‑flow treatment. It only enumerates award dates and share counts associated with deferred compensation entries.